ONE Bio Corp.

ONBI · Other OTC · USD

0,0005USD

0,00 (0,00 %)Stand 9. Nov., 21:00

Vortag 0,0005

Kennzahlen

Eröffnung
0,0005
Vortag
0,0005
Tagesspanne
0,0005 – 0,003
52 Wochen
0,0002 – 0,003
Volumen
5764
Ø Volumen
5508
Börsenwert
4235 $
KGV
0,0
Gewinn je Aktie (TTM)
0,89
Dividendenrendite
0,0 %
Beta
6,0
Nächste Zahlen
–

Finanzen

USDFY 2010FY 2009FY 2008FY 2007FY 2006
Umsatz52,3 Mio.22,07 Mio.78.240578.590207.507
Herstellungskosten32,17 Mio.12,09 Mio.43.906194.86969.000
Bruttogewinn20,13 Mio.9,98 Mio.34.334383.721138.505
Forschung und Entwicklung259.878378.497000
Vertrieb und Verwaltung6,18 Mio.2,15 Mio.59.064333.717129.544
Operatives Ergebnis13,68 Mio.7,46 Mio.−34.26542.855−11.359,65
EBITDA13,61 Mio.8,02 Mio.−25.256−4382,27132.324
Nettogewinn8,68 Mio.4,77 Mio.−42.13637.258−3789,14
Gewinn je Aktie (verwässert)1,350,93-0,01-0,01-0,06

Bewertung

Letzte 12 Monate

KGV
0,0
Kurs-Umsatz-Verhältnis
0,0
Kurs-Buchwert-Verhältnis
0,0
PEG
-0,0
Bruttomarge
38,5 %
Operative Marge
26,2 %
Nettomarge
16,6 %
Verschuldungsgrad
0,5
EV/EBITDA
0,7
Eigenkapitalrendite
24,3 %
Kapitalrendite (ROIC)
16,1 %
Free-Cashflow-Rendite
108.922,1 %
FY 2010FY 2009FY 2008FY 2007FY 2006
Bruttomarge38,5 %45,2 %43,9 %66,3 %66,7 %
Operative Marge26,2 %33,8 %−43,8 %7,4 %−5,5 %
Nettomarge16,6 %21,6 %−53,9 %6,4 %−1,8 %
KGV4,531,7-2.010,13.233,7-524,7
Kurs-Umsatz-Verhältnis0,86,81.079,4209,09,6
Kurs-Buchwert-Verhältnis0,95,1-3.239,01.917,057,1
Verschuldungsgrad0,50,6-0,91,31,4
Liquidität 3. Grades1,51,60,47,91,2
Dividendenrendite0,0 %0,0 %0,0 %0,0 %0,0 %
Unternehmenswert48,34 Mio.163,27 Mio.84,47 Mio.120,88 Mio.2,03 Mio.
EV/EBITDA3,620,3-3.344,7-27.582,915,3
Eigenkapitalrendite20,6 %16,2 %161,6 %59,1 %−10,9 %
Kapitalrendite (ROIC)16,1 %10,8 %1.418,8 %20,7 %−13,7 %
Free-Cashflow-Rendite11,7 %−1,4 %0,0 %0,0 %−1,4 %

Wachstum

FY 2010FY 2009FY 2008FY 2007FY 2006
Umsatz+136,9 %+28.112,2 %−86,5 %+178,8 %+26,7 %
Bruttogewinn+101,6 %+28.979,6 %−91,1 %+177,0 %+0,1 %
Operatives Ergebnis+83,4 %+21.867,8 %−180,0 %+477,3 %+77,9 %
Nettogewinn+81,8 %+11.427,2 %−213,1 %+1.083,3 %−121,8 %
Gewinn je Aktie+45,2 %+6.839,1 %−112,3 %+88,5 %−122,7 %
Freier Cashflow+313,8 %−10.532,6 %−49,6 %+244,7 %+39,1 %
Dividende je Aktie0,0 %0,0 %0,0 %0,0 %0,0 %

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gewinn je Aktie · Erwartet
Gewinn je Aktie · Tatsächlich
Abweichung
Umsatz · Tatsächlich

Dividenden und Splits

Keine Dividenden gezahlt.

Aktiensplits

  • 15. Sept. 20101:5
  • 17. Nov. 20091:5

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

–

Vergleichbare Unternehmen

Über das Unternehmen

ONE Bio Corp. functions as an agritech enterprise that, alongside its subsidiaries, employs eco-friendly manufacturing methods to develop and produce foundational chemicals, botanical extracts, health supplements, and organic goods. The company's operations are divided into two primary segments: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE division is dedicated to the creation, production, and market introduction of bio-ecological and non-prescription items. These products are formulated using compounds extracted from tobacco leaves and various other plant sources. Its offerings encompass chemical extracts such as Solanesol and Coenzyme Q10, in addition to herbal extracts like Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea, alongside granular and powdered fertilizers. Distribution for CHE products within China's bio-health and raw chemical intermediates sectors occurs through a network of independent third-party distributors, academic institutions, and hospital research facilities. Meanwhile, the OP unit manufactures a diverse array of health and energy beverages for both consumer and commercial use, organic food products, and fertilizers. These products, primarily bamboo-based, are marketed within the People's Republic of China. Its portfolio includes standard and vacuum-packed canned bamboo shoots, prepared mixed and seasoned vegetables, and the Japanese rice delicacy known as Kamameshi. This segment delivers its merchandise directly to supermarket chains, hotels, hospitals, and restaurants, augmented by sales through independent third-party distributors. Globally, ONE Bio Corp. exports its products to Japan, various Southeast Asian nations, European markets, and North America. Founded in 2000, the company was rebranded from ONE Holdings, Corp. to ONE Bio Corp. in November 2009 and is based in Aventura, Florida.

Führung

  • Jian Ming ChanChairman of the Advisory Board & Chief Scientist
  • Jerold SieganGeneral Counsel
  • Min ZhaoDirector & President of China Operations
CEO
Jian Ming Chan
Mitarbeitende
358
Hauptsitz
Aventura, FL, US
Sektor
Basic Materials
Branche
Chemicals - Specialty
Börsengang
15. Sept. 2009

Nachrichten

Gerade keine Nachrichten zu diesem Unternehmen.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.